Differentiating Radiation Necrosis from Brain Tumor Using Hyperpolarized Carbon-13 MR Metabolic Imaging
- 13 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Imaging & Biology
- Vol. 23 (3), 417-426
- https://doi.org/10.1007/s11307-020-01574-w
Abstract
Purpose Differentiation between radiation-induced necrosis and tumor recurrence is crucial to determine proper management strategies but continues to be one of the central challenges in neuro-oncology. We hypothesized that hyperpolarized 13C MRI, a unique technique to measure real-time in vivo metabolism, would distinguish radiation necrosis from tumor on the basis of cell-intrinsic metabolic differences. The purpose of this study was to explore the feasibility of using hyperpolarized [1-13C]pyruvate for differentiating radiation necrosis from brain tumors. Procedures Radiation necrosis was initiated by employing a CT-guided 80-Gy single-dose irradiation of a half cerebrum in mice (n = 7). Intracerebral tumor was modeled with two orthotopic mouse models: GL261 glioma (n = 6) and Lewis lung carcinoma (LLC) metastasis (n = 7). 13C 3D MR spectroscopic imaging data were acquired following hyperpolarized [1-13C]pyruvate injection approximately 89 and 14 days after treatment for irradiated and tumor-bearing mice, respectively. The ratio of lactate to pyruvate (Lac/Pyr), normalized lactate, and pyruvate in contrast-enhancing lesion was compared between the radiation-induced necrosis and brain tumors. Histopathological analysis was performed from resected brains. Results Conventional MRI exhibited typical radiographic features of radiation necrosis and brain tumor with large areas of contrast enhancement and T2 hyperintensity in all animals. Normalized lactate in radiation necrosis (0.10) was significantly lower than that in glioma (0.26, P = .004) and LLC metastatic tissue (0.25, P = .00007). Similarly, Lac/Pyr in radiation necrosis (0.18) was significantly lower than that in glioma (0.55, P = .00008) and LLC metastasis (0.46, P = .000008). These results were consistent with histological findings where tumor-bearing brains were highly cellular, while irradiated brains exhibited pathological markers consistent with reparative changes from radiation necrosis. Conclusion Hyperpolarized 13C MR metabolic imaging of pyruvate is a noninvasive imaging method that differentiates between radiation necrosis and brain tumors, providing a groundwork for further clinical investigation and translation for the improved management of patients with brain tumors.Keywords
Funding Information
- Ministry of Science and ICT (2017R1C1B5018396)
- Ministry of Education (2019R1I1A3A01059201)
- American Brain Tumor Association (DG1700010)
- Ministry of Health and Welfare (HR20C0021)
- DongKook Life Science. Co., Ltd.
This publication has 42 references indexed in Scilit:
- SIVIC: Open-Source, Standards-Based Software for DICOM MR Spectroscopy WorkflowsInternational Journal of Biomedical Imaging, 2013
- In vivo mouse cardiac hyperpolarized magnetic resonance spectroscopyJournal of Cardiovascular Magnetic Resonance, 2013
- Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13 C magnetic resonance spectroscopic imagingMagnetic Resonance in Medicine, 2012
- Lactate: A Metabolic Key Player in CancerCancer Research, 2011
- Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptidesNature Medicine, 2010
- Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1‐13C]pyruvate and 13C magnetic resonance spectroscopic imagingMagnetic Resonance in Medicine, 2010
- Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivoJournal of Magnetic Resonance, 2010
- Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumorsNeuro-Oncology, 2010
- Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR ImagingRadiology, 2009
- On the Origin of Cancer CellsScience, 1956